Universe Pharmaceuticals INC 20-F for FY2023
Universe Pharmaceuticals INC (UPC)
20-F
2024-01-30
For: 2023-09-30
View Original
Added on
April 09, 2026
About this 20-F
Universe Pharmaceuticals INC filed this 20-F on January 30, 2024, covering the fiscal year ended September 30, 2023 (FY2023).
Headline figures
Fiscal year ended September 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $32.31M
- down 19.5% from $40.14M a year earlier
- Net loss
- $6.16M
- compared with a net loss of $8.74M a year earlier
- Diluted EPS
- -$1.70
- compared with -$2.41 a year earlier